Prevention of Atrial Fibrillation. Karin Prussak, DNP, ARNP Florida ACC August 17, 2013. Objectives . Evaluate the economic burden of AF List the most common risk factors of AF. Identify risk factor modification to decrease risk of AF based on current research studies.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Karin Prussak, DNP, ARNP
August 17, 2013
legislation, which includes an optional public insurance program
H.R. 3590 authors project that 94% of the U.S. population will have health coverage and does not include a public insurance option
Lip, Kakar & Watson, 2007; Go, et al., 2001; Chen & Shen, 2007.
Fuster, V., et al. (2001). ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation. Circulation, 104, 2120.
$6.65 billion in total treatment costs:
Hospital: $4.88 billion
Outpatient: $1.53 billion
Medications: $235 million
Coyne, et al. (2006).
Lloyd-Jones et al. 2004; Ruigomez, Johannson, Wallander & Rodriguez 2002.
Valvular Disease (RHD)
Coronary Artery Disease
Obstructive Sleep Apnea
Cardiothoracic surgery: CABG and valvular surgery
Previous episodes of AF
Esophageal resectionKnown Risk Factors of AF
Wu et al., 2005; Chen & Shen, 2007; Gami et al., 2007; Lip et al., 2007; Watanabe et al., 2008; Fuster et al., 2006; Otway, Vandenburg & Fatkin, 2007.
Expression of angiotension-converting enzyme increased 3-fold during persistent AF
Increase in left ventricular hypertrophy led to increase in left atrial dimension which increases the risk of AF
Atrial stretch can cause AF and AF can cause atrial dilation
Autonomic Nervous System activity
LV diastolic dysfunction affects stretch receptors in the pulmonary veins or directly affects atrial myocardium.Pathophysiology of AF
Increased Left Atrial Diameter (LAD)
New Onset Atrial Fibrillation
Left Ventricular Enlargement or Hypertrophy
Heart FailureAF Risk Factor Causal Model
Prussak, K. (2008). Prevention of New-Onset Atrial Fibrillation.
Fuster, et al. 2006.
Significant difference noted in LAD in obese men compared to overweight men (p<.001).
Increased risk of AF with increased LAD and LVH.Obesity and AF
Wang, T. et al.JAMA, 2004; Pritchett, A. et al.J Am Coll Cardiol, 2003; Frost, Hune & Vestergaard, Am J Med, 2005;
Ruigomez,,A. et al.,J Am Epidem, 2002; Gami, A. et al., J Am Coll Cardiol, 2004.
Kanagala, R., et al. (2003). Circulation; Gami, A., et al. (2007). J Am Coll Cardiol
Okin, P., et al.(2006). JAMA.
Maisel, W. et al. (2003). Am J Cardiol; Stevenson, S., et al. (1999). N Engl J Med.
Vermes, E., et al. (2003). Circ.
Jayaprasad, N. & Johnson, F. (2005). Indian Pacing Electrophysiol J.
Watanabe, H., et al. (2008). Circ.
Creswell, et al. (1993)
Fuster, et. al. (2006); Calo, et al. (2005); Saravannan et al. (2009).
Aizer, A. et al., Heart Rhythm, 2006; Brouwer, I., et al., Am Heart J, 2006; Calo, L., et al., J Am Coll Cardiol, 2005; Frost, L., et al., Am J.Clin Nutr, 2005;
Mozaffarian, D. et al. Circ, 2004; Saravanan, P., et al., Heart Rhythm, 2009.
Anti-oxidant and Anti-inflammatory
Carnes, C. et al. (2001). Circ; Korantzopoulos, P. et al.(2005). Int J Card.
Pellegrini, C., et al. Heart Rhythm Society (HRS) Annual Scientific Sessions; May 14-17, 2008,
Fauchier, L., et al. (2008). J Am Coll Cardiol.
Savelieva, I., et al. (2011). Europace.